{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T17:15:37Z","timestamp":1793121337719,"version":"4.5.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,1,9]],"date-time":"2024-01-09T00:00:00Z","timestamp":1704758400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,1,9]],"date-time":"2024-01-09T00:00:00Z","timestamp":1704758400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Doxorubicin (DOX) is a popular and potent anticancer drug, but its cardiotoxicity limits its clinical application. Shikonin has a wide range of biological functions, including antioxidant and anti-inflammatory effects. The aim of this study was to investigate the effects of shikonin on DOX-induced cardiac injury and to identify the underlying mechanisms. Mice receiving shikonin showed reduced cardiac injury response and enhanced cardiac function after DOX administration. Shikonin significantly attenuated DOX-induced oxidative damage, inflammation accumulation and cardiomyocyte apoptosis. Shikonin protects against DOX-induced cardiac injury by inhibiting Mammalian sterile 20-like kinase 1 (Mst1) and oxidative stress and activating the nuclear factor erythroid 2-related factor 2 (Nrf2) pathway. In conclusion, shikonin alleviates DOX-induced cardiotoxicity by inhibiting Mst1 and activating Nrf2. Shikonin may be used to treat DOX-induced cardiac injury.<\/jats:p>","DOI":"10.1038\/s41598-024-51675-7","type":"journal-article","created":{"date-parts":[[2024,1,9]],"date-time":"2024-01-09T18:02:33Z","timestamp":1704823353000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Shikonin alleviates doxorubicin-induced cardiotoxicity via Mst1\/Nrf2 pathway in mice"],"prefix":"10.1038","volume":"14","author":[{"given":"Hu","family":"Tuo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danni","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,1,9]]},"reference":[{"key":"51675_CR1","doi-asserted-by":"publisher","first-page":"3267","DOI":"10.2174\/092986709788803312","volume":"16","author":"C Carvalho","year":"2009","unstructured":"Carvalho, C. et al. Doxorubicin: The good, the bad and the ugly effect. Curr. Med. Chem. 16, 3267\u20133285 (2009).","journal-title":"Curr. Med. Chem."},{"key":"51675_CR2","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1056\/NEJM199809243391307","volume":"339","author":"PK Singal","year":"1998","unstructured":"Singal, P. K. & Iliskovic, N. Doxorubicin-induced cardiomyopathy. N. Engl. J. Med. 339, 900\u2013905 (1998).","journal-title":"N. Engl. J. Med."},{"key":"51675_CR3","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1161\/CIRCRESAHA.119.314681","volume":"126","author":"KB Wallace","year":"2020","unstructured":"Wallace, K. B., Sardao, V. A. & Oliveira, P. J. Mitochondrial determinants of doxorubicin-induced cardiomyopathy. Circ. Res. 126, 926\u2013941 (2020).","journal-title":"Circ. Res."},{"key":"51675_CR4","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1007\/s10565-008-9070-1","volume":"25","author":"VA Sardao","year":"2009","unstructured":"Sardao, V. A., Oliveira, P. J., Holy, J., Oliveira, C. R. & Wallace, K. B. Morphological alterations induced by doxorubicin on H9c2 myoblasts: Nuclear, mitochondrial, and cytoskeletal targets. Cell Biol. Toxicol. 25, 227\u2013243 (2009).","journal-title":"Cell Biol. Toxicol."},{"key":"51675_CR5","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/j.crvi.2005.08.007","volume":"329","author":"M Tokarska-Schlattner","year":"2006","unstructured":"Tokarska-Schlattner, M., Wallimann, T. & Schlattner, U. Alterations in myocardial energy metabolism induced by the anti-cancer drug doxorubicin. C. R. Biol. 329, 657\u2013668 (2006).","journal-title":"C. R. Biol."},{"key":"51675_CR6","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1161\/CIRCRESAHA.117.311335","volume":"122","author":"SK Gupta","year":"2018","unstructured":"Gupta, S. K. et al. Quaking inhibits doxorubicin-mediated cardiotoxicity through regulation of cardiac circular RNA expression. Circ. Res. 122, 246\u2013254 (2018).","journal-title":"Circ. Res."},{"key":"51675_CR7","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1161\/CIRCULATIONAHA.113.003688","volume":"128","author":"T Force","year":"2013","unstructured":"Force, T. & Wang, Y. Mechanism-based engineering against anthracycline cardiotoxicity. Circulation 128, 98\u2013100 (2013).","journal-title":"Circulation"},{"key":"51675_CR8","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/j.freeradbiomed.2015.05.036","volume":"88","author":"H Zhang","year":"2015","unstructured":"Zhang, H., Davies, K. J. A. & Forman, H. J. Oxidative stress response and Nrf2 signaling in aging. Free Radic. Biol. Med. 88, 314\u2013336 (2015).","journal-title":"Free Radic. Biol. Med."},{"key":"51675_CR9","doi-asserted-by":"publisher","first-page":"4817","DOI":"10.3390\/nu14224817","volume":"14","author":"R Ben Ammar","year":"2022","unstructured":"Ben Ammar, R. et al. Anti-inflammatory activity of geraniol isolated from lemon grass on Ox-LDL-stimulated endothelial cells by upregulation of heme oxygenase-1 via PI3K\/Akt and Nrf-2 signaling pathways. Nutrients 14, 4817 (2022).","journal-title":"Nutrients"},{"key":"51675_CR10","doi-asserted-by":"publisher","first-page":"5585303","DOI":"10.1155\/2021\/5585303","volume":"2021","author":"P Rajendran","year":"2021","unstructured":"Rajendran, P., Alzahrani, A. M., Ahmed, E. A. & Veeraraghavan, V. P. Kirenol inhibits B[a]P-induced oxidative stress and apoptosis in endothelial cells via modulation of the Nrf2 signaling pathway. Oxid. Med. Cell Longev. 2021, 5585303 (2021).","journal-title":"Oxid. Med. Cell Longev."},{"key":"51675_CR11","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1002\/ptr.1100","volume":"16","author":"X Chen","year":"2002","unstructured":"Chen, X., Yang, L., Oppenheim, J. J. & Howard, M. Z. Cellular pharmacology studies of shikonin derivatives. Phytother. Res. 16, 199\u2013209 (2002).","journal-title":"Phytother. Res."},{"key":"51675_CR12","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1055\/s-0033-1350934","volume":"79","author":"I Andujar","year":"2013","unstructured":"Andujar, I., Rios, J. L., Giner, R. M. & Recio, M. C. Pharmacological properties of shikonin\u2014A review of literature since 2002. Planta Med. 79, 1685\u20131697 (2013).","journal-title":"Planta Med."},{"key":"51675_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3164\/jcbn.16-4","volume":"59","author":"K Kazumura","year":"2016","unstructured":"Kazumura, K. et al. Inhibition of neutrophil superoxide generation by shikonin is associated with suppression of cellular Ca(2+) fluxes. J. Clin. Biochem. Nutr. 59, 1\u20139 (2016).","journal-title":"J. Clin. Biochem. Nutr."},{"key":"51675_CR14","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1007\/s10495-019-01528-w","volume":"24","author":"D Bergamaschi","year":"2019","unstructured":"Bergamaschi, D. et al. Simultaneous polychromatic flow cytometric detection of multiple forms of regulated cell death. Apoptosis 24, 453\u2013464 (2019).","journal-title":"Apoptosis"},{"key":"51675_CR15","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.ejps.2013.02.003","volume":"49","author":"C Chen","year":"2013","unstructured":"Chen, C., Shanmugasundaram, K., Rigby, A. C. & Kung, A. L. Shikonin, a natural product from the root of Lithospermum erythrorhizon, is a cytotoxic DNA-binding agent. Eur. J. Pharm. Sci. 49, 18\u201326 (2013).","journal-title":"Eur. J. Pharm. Sci."},{"key":"51675_CR16","doi-asserted-by":"publisher","first-page":"2639","DOI":"10.3892\/ijo.2016.3454","volume":"48","author":"C Li","year":"2016","unstructured":"Li, C. et al. Inhibitory role of TRIP-Br 1 oncoprotein in hypoxia-induced apoptosis in breast cancer cell lines. Int. J. Oncol. 48, 2639\u20132646 (2016).","journal-title":"Int. J. Oncol."},{"key":"51675_CR17","doi-asserted-by":"publisher","first-page":"386","DOI":"10.3389\/fphar.2017.00386","volume":"8","author":"SY Yin","year":"2017","unstructured":"Yin, S. Y., Yang, N. S. & Lin, T. J. Phytochemicals approach for developing cancer immunotherapeutics. Front. Pharmacol. 8, 386 (2017).","journal-title":"Front. Pharmacol."},{"key":"51675_CR18","doi-asserted-by":"publisher","first-page":"570441","DOI":"10.3389\/fphys.2020.570441","volume":"11","author":"T Guo","year":"2020","unstructured":"Guo, T. et al. Shikonin ameliorates LPS-induced cardiac dysfunction by SIRT1-dependent inhibition of NLRP3 inflammasome. Front. Physiol. 11, 570441 (2020).","journal-title":"Front. Physiol."},{"key":"51675_CR19","doi-asserted-by":"publisher","first-page":"4334","DOI":"10.1080\/07391102.2020.1776157","volume":"39","author":"S Gupta","year":"2021","unstructured":"Gupta, S. et al. Identification of potential natural inhibitors of SARS-CoV2 main protease by molecular docking and simulation studies. J. Biomol. Struct. Dyn. 39, 4334\u20134345 (2021).","journal-title":"J. Biomol. Struct. Dyn."},{"key":"51675_CR20","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1139\/cjpp-2015-0465","volume":"94","author":"B Gupta","year":"2016","unstructured":"Gupta, B. et al. Antinociceptive properties of shikonin: In vitro and in vivo studies. Can. J. Physiol. Pharmacol. 94, 788\u2013796 (2016).","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"51675_CR21","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1016\/j.jff.2015.04.040","volume":"16","author":"SY Gwon","year":"2015","unstructured":"Gwon, S. Y. et al. Shikonin protects against obesity through the modulation of adipogenesis, lipogenesis, and \u03b2-oxidation in vivo. J. Funct. Foods 16, 484\u2013493 (2015).","journal-title":"J. Funct. Foods"},{"key":"51675_CR22","first-page":"148","volume":"28","author":"L Gan","year":"2015","unstructured":"Gan, L. et al. Protective effects of shikonin on brain injury induced by carbon ion beam irradiation in mice. Biomed. Environ. Sci. 28, 148\u2013151 (2015).","journal-title":"Biomed. Environ. Sci."},{"key":"51675_CR23","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/j.bbrc.2019.10.038","volume":"520","author":"WL Liu","year":"2019","unstructured":"Liu, W. L. & Liu, Q. Shikonin attenuates sympathetic remodeling in chronic heart failure mice via regulating miR-124. Biochem. Biophys. Res. Commun. 520, 359\u2013365 (2019).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"51675_CR24","doi-asserted-by":"publisher","first-page":"10711","DOI":"10.1111\/jcmm.17007","volume":"25","author":"X Zhang","year":"2021","unstructured":"Zhang, X. et al. PKM2 promotes angiotensin-II-induced cardiac remodelling by activating TGF-beta\/Smad2\/3 and Jak2\/Stat3 pathways through oxidative stress. J. Cell Mol. Med. 25, 10711\u201310723 (2021).","journal-title":"J. Cell Mol. Med."},{"key":"51675_CR25","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1016\/j.biopha.2017.06.086","volume":"93","author":"J Yang","year":"2017","unstructured":"Yang, J., Wang, Z. & Chen, D. L. Shikonin ameliorates isoproterenol (ISO)-induced myocardial damage through suppressing fibrosis, inflammation, apoptosis and ER stress. Biomed. Pharmacother. 93, 1343\u20131357 (2017).","journal-title":"Biomed. Pharmacother."},{"key":"51675_CR26","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1093\/abbs\/gmz135","volume":"52","author":"X Zhao","year":"2020","unstructured":"Zhao, X. et al. PKM2-dependent glycolysis promotes the proliferation and migration of vascular smooth muscle cells during atherosclerosis. Acta Biochim. Biophys. Sin. (Shanghai) 52, 9\u201317 (2020).","journal-title":"Acta Biochim. Biophys. Sin. (Shanghai)"},{"key":"51675_CR27","doi-asserted-by":"publisher","first-page":"3303","DOI":"10.1038\/ncomms4303","volume":"5","author":"DS Jiang","year":"2014","unstructured":"Jiang, D. S. et al. IRF8 suppresses pathological cardiac remodelling by inhibiting calcineurin signalling. Nat. Commun. 5, 3303 (2014).","journal-title":"Nat. Commun."},{"key":"51675_CR28","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1007\/978-1-59745-571-8_16","volume":"139","author":"R Liao","year":"2007","unstructured":"Liao, R. & Jain, M. Isolation, culture, and functional analysis of adult mouse cardiomyocytes. Methods Mol. Med. 139, 251\u2013262 (2007).","journal-title":"Methods Mol. Med."},{"key":"51675_CR29","doi-asserted-by":"publisher","first-page":"305","DOI":"10.3109\/10611860008997908","volume":"8","author":"F Kratz","year":"2000","unstructured":"Kratz, F. et al. In vitro and in vivo efficacy of acid-sensitive transferrin and albumin doxorubicin conjugates in a human xenograft panel and in the MDA-MB-435 mamma carcinoma model. J. Drug Target 8, 305\u2013318 (2000).","journal-title":"J. Drug Target"},{"key":"51675_CR30","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1002\/dneu.22796","volume":"81","author":"MR Sahu","year":"2021","unstructured":"Sahu, M. R. & Mondal, A. C. Neuronal Hippo signaling: From development to diseases. Dev. Neurobiol. 81, 92\u2013109 (2021).","journal-title":"Dev. Neurobiol."},{"key":"51675_CR31","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1161\/01.RES.0000265846.23485.7a","volume":"100","author":"M Odashima","year":"2007","unstructured":"Odashima, M. et al. Inhibition of endogenous Mst1 prevents apoptosis and cardiac dysfunction without affecting cardiac hypertrophy after myocardial infarction. Circ. Res. 100, 1344\u20131352 (2007).","journal-title":"Circ. Res."},{"key":"51675_CR32","doi-asserted-by":"publisher","first-page":"2435","DOI":"10.1007\/s00125-016-4070-9","volume":"59","author":"M Zhang","year":"2016","unstructured":"Zhang, M. et al. MST1 coordinately regulates autophagy and apoptosis in diabetic cardiomyopathy in mice. Diabetologia 59, 2435\u20132447 (2016).","journal-title":"Diabetologia"},{"key":"51675_CR33","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/s12576-018-0627-3","volume":"69","author":"W Yu","year":"2019","unstructured":"Yu, W., Xu, M., Zhang, T., Zhang, Q. & Zou, C. Mst1 promotes cardiac ischemia-reperfusion injury by inhibiting the ERK-CREB pathway and repressing FUNDC1-mediated mitophagy. J. Physiol. Sci. 69, 113\u2013127 (2019).","journal-title":"J. Physiol. Sci."},{"key":"51675_CR34","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.freeradbiomed.2014.03.001","volume":"72","author":"Y Zhao","year":"2014","unstructured":"Zhao, Y. et al. Redox proteomic identification of HNE-bound mitochondrial proteins in cardiac tissues reveals a systemic effect on energy metabolism after doxorubicin treatment. Free Radic. Biol. Med. 72, 55\u201365 (2014).","journal-title":"Free Radic. Biol. Med."},{"key":"51675_CR35","doi-asserted-by":"publisher","first-page":"108704","DOI":"10.1016\/j.biopha.2019.108704","volume":"112","author":"H Guo","year":"2019","unstructured":"Guo, H. et al. Shikonin attenuates acetaminophen-induced acute liver injury via inhibition of oxidative stress and inflammation. Biomed. Pharmacother. 112, 108704 (2019).","journal-title":"Biomed. Pharmacother."},{"key":"51675_CR36","doi-asserted-by":"publisher","first-page":"44785","DOI":"10.1038\/srep44785","volume":"7","author":"T Liu","year":"2017","unstructured":"Liu, T. et al. The protective effects of shikonin on hepatic ischemia\/reperfusion injury are mediated by the activation of the PI3K\/Akt pathway. Sci. Rep. 7, 44785 (2017).","journal-title":"Sci. Rep."},{"key":"51675_CR37","doi-asserted-by":"publisher","first-page":"152","DOI":"10.2174\/157489210790936261","volume":"5","author":"HL Liu","year":"2010","unstructured":"Liu, H. L., Jiang, W. B. & Xie, M. X. Flavonoids: Recent advances as anticancer drugs. Recent Patents Anti-cancer Drug Discov. 5, 152\u2013164 (2010).","journal-title":"Recent Patents Anti-cancer Drug Discov."},{"key":"51675_CR38","doi-asserted-by":"publisher","first-page":"3269","DOI":"10.3390\/ijms22063269","volume":"22","author":"AM Alzahrani","year":"2021","unstructured":"Alzahrani, A. M., Rajendran, P., Veeraraghavan, V. P. & Hanieh, H. Cardiac protective effect of kirenol against doxorubicin-induced cardiac hypertrophy in H9c2 cells through Nrf2 signaling via PI3K\/AKT pathways. Int. J. Mol. Sci. 22, 3269 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"51675_CR39","doi-asserted-by":"publisher","first-page":"748524","DOI":"10.1155\/2014\/748524","volume":"2014","author":"S Li","year":"2014","unstructured":"Li, S. et al. Nrf2 deficiency exaggerates doxorubicin-induced cardiotoxicity and cardiac dysfunction. Oxid. Med. Cell Longev. 2014, 748524 (2014).","journal-title":"Oxid. Med. Cell Longev."},{"key":"51675_CR40","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.freeradbiomed.2015.05.028","volume":"86","author":"P Singh","year":"2015","unstructured":"Singh, P. et al. Sulforaphane protects the heart from doxorubicin-induced toxicity. Free Radic. Biol. Med. 86, 90\u2013101 (2015).","journal-title":"Free Radic. Biol. Med."},{"key":"51675_CR41","doi-asserted-by":"publisher","first-page":"829642","DOI":"10.3389\/fnmol.2022.829642","volume":"15","author":"H Du","year":"2022","unstructured":"Du, H. et al. Shikonin attenuates cochlear spiral ganglion neuron degeneration by activating Nrf2-ARE signaling pathway. Front. Mol. Neurosci. 15, 829642 (2022).","journal-title":"Front. Mol. Neurosci."},{"key":"51675_CR42","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1172\/JCI17459","volume":"111","author":"S Yamamoto","year":"2003","unstructured":"Yamamoto, S. et al. Activation of Mst1 causes dilated cardiomyopathy by stimulating apoptosis without compensatory ventricular myocyte hypertrophy. J. Clin. Investig. 111, 1463\u20131474 (2003).","journal-title":"J. Clin. Investig."},{"key":"51675_CR43","doi-asserted-by":"publisher","first-page":"R421","DOI":"10.1016\/j.cub.2009.04.022","volume":"19","author":"M Radu","year":"2009","unstructured":"Radu, M. & Chernoff, J. The DeMSTification of mammalian Ste20 kinases. Curr. Biol. 19, R421\u2013R425 (2009).","journal-title":"Curr. Biol."},{"key":"51675_CR44","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.toxlet.2022.10.005","volume":"373","author":"C Zhang","year":"2023","unstructured":"Zhang, C. et al. Rab10 protects against DOX-induced cardiotoxicity by alleviating the oxidative stress and apoptosis of cardiomyocytes. Toxicol. Lett. 373, 84\u201393 (2023).","journal-title":"Toxicol. Lett."},{"key":"51675_CR45","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1038\/s41467-019-08680-6","volume":"10","author":"P Wang","year":"2019","unstructured":"Wang, P. et al. Macrophage achieves self-protection against oxidative stress-induced ageing through the Mst-Nrf2 axis. Nat. Commun. 10, 755 (2019).","journal-title":"Nat. Commun."},{"key":"51675_CR46","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1186\/s13287-020-02041-7","volume":"11","author":"Q Zhang","year":"2020","unstructured":"Zhang, Q. et al. Dissecting molecular mechanisms underlying H(2)O(2)-induced apoptosis of mouse bone marrow mesenchymal stem cell: Role of Mst1 inhibition. Stem Cell Res. Ther. 11, 526 (2020).","journal-title":"Stem Cell Res. Ther."},{"key":"51675_CR47","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1007\/s00395-018-0693-y","volume":"113","author":"A Deussen","year":"2018","unstructured":"Deussen, A. Mechanisms underlying coronary autoregulation continue to await clarification. Basic Res. Cardiol. 113, 34 (2018).","journal-title":"Basic Res. Cardiol."},{"key":"51675_CR48","doi-asserted-by":"publisher","first-page":"23774","DOI":"10.1002\/jcp.28945","volume":"234","author":"H Song","year":"2019","unstructured":"Song, H., Wang, M. & Xin, T. Mst1 contributes to nasal epithelium inflammation via augmenting oxidative stress and mitochondrial dysfunction in a manner dependent on Nrf2 inhibition. J. Cell Physiol. 234, 23774\u201323784 (2019).","journal-title":"J. Cell Physiol."},{"key":"51675_CR49","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1016\/j.redox.2013.08.002","volume":"1","author":"RT Kolamunne","year":"2013","unstructured":"Kolamunne, R. T., Dias, I. H., Vernallis, A. B., Grant, M. M. & Griffiths, H. R. Nrf2 activation supports cell survival during hypoxia and hypoxia\/reoxygenation in cardiomyoblasts: The roles of reactive oxygen and nitrogen species. Redox Biol. 1, 418\u2013426 (2013).","journal-title":"Redox Biol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-51675-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-51675-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-51675-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,9]],"date-time":"2024-01-09T19:06:54Z","timestamp":1704827214000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-51675-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,9]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["51675"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-51675-7","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,9]]},"assertion":[{"value":"3 September 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 January 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 January 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"924"}}